APOE and Alzheimer disease: In AD patients, regional hypometabolism in the brain is a predictor for progressive cognitive decline and reduced cerebral metabolism is associated with carriers of the AD risk allele of the APOE-4 gene (Small et al., 1995; Silverman et al., 2001).